CBD by Condition? Why Retail Dosing Charts Are Misleading
CBD condition dosing charts can look authoritative while mixing unrelated studies, retail products and medical conditions. That is not a reliable basis for self-treatment.
Anxiety and Mood
Clinical research uses defined formulations, doses and populations. It should not be converted into a retail “mg per day” recommendation for anxiety, panic or depression.
Sleep
Evidence for CBD and sleep is mixed. A fixed bedtime dose is not an evidence-based recommendation for insomnia.
Pain and Recovery
CBD-only evidence for chronic pain remains limited. Retail oils or creams should not be assigned dosing targets for arthritis, surgery, injury or stroke recovery.
Neurological Conditions
Epilepsy and other neurological conditions require specialist medical care. Research doses for prescription cannabidiol are not retail recommendations.
Substance Use Disorders
Experimental research into cannabinoids and craving does not justify unsupervised high-dose CBD for nicotine or opioid withdrawal.
What to Do Instead
Use product-label guidance for ordinary retail products and seek clinician input when CBD is being considered for a medical condition.
Bottom Line
Condition-specific CBD dosing belongs in clinical care, not a general ecommerce blog.
